Cargando…
Multivariable Regression Analysis in Schistosoma mansoni-Infected Individuals in the Sudan Reveals Unique Immunoepidemiological Profiles in Uninfected, egg+ and Non-egg+ Infected Individuals
BACKGROUND: In the Sudan, Schistosoma mansoni infections are a major cause of morbidity in school-aged children and infection rates are associated with available clean water sources. During infection, immune responses pass through a Th1 followed by Th2 and Treg phases and patterns can relate to diff...
Autores principales: | Elfaki, Tayseer Elamin Mohamed, Arndts, Kathrin, Wiszniewsky, Anna, Ritter, Manuel, Goreish, Ibtisam A., Atti El Mekki, Misk El Yemen A., Arriens, Sandra, Pfarr, Kenneth, Fimmers, Rolf, Doenhoff, Mike, Hoerauf, Achim, Layland, Laura E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859533/ https://www.ncbi.nlm.nih.gov/pubmed/27152725 http://dx.doi.org/10.1371/journal.pntd.0004629 |
Ejemplares similares
-
Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021) -
Immunoepidemiological Profiling of Onchocerciasis Patients Reveals Associations with Microfilaria Loads and Ivermectin Intake on Both Individual and Community Levels
por: Arndts, Kathrin, et al.
Publicado: (2014) -
Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals
por: Arndts, Kathrin, et al.
Publicado: (2015) -
Distinct Immune Profiles of Exhausted Effector and Memory CD8(+) T Cells in Individuals With Filarial Lymphedema
por: Horn, Sacha, et al.
Publicado: (2021) -
Reduced Type 2 Innate Lymphocyte Cell Frequencies in Patent Wuchereria bancrofti-Infected Individuals
por: Tamadaho, Ruth S. E., et al.
Publicado: (2023)